KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
for
Solid Tumors With HRAS Alterations,
Location: Boston MA, New Brunswick NJ, Pittsburgh PA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06026410
Phase1, Recruiting
Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05336812
Phase2, Recruiting
A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma
for
Solid Tumor, Adult, Lymphoma
Location: Houston TX, Duarte CA
Sponsor: Cyclacel Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT04983810
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
for
Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT00131014
Recruiting
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
for
IDH1 wt Allele, Recurrent Anaplastic Astrocytoma,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03896568
Phase1, Recruiting
Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL
for
Lymphoma, Primary Central Nervous System Lymphoma
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT06475235
Phase1, Recruiting
Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
for
Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma,
Location: Rochester MN, Scottsdale AZ
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06508463
Phase1, Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma,
Location: Columbus OH, Sioux Falls SD, Orange CA, Eugene OR
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT01804686
Phase3, Recruiting
Manual Immediately Sequential Bilateral Cataract Surgery (M-ISBCS) vs Refractive Laser-Assisted Immediately Sequential Bilateral Cataract Surgery (ReLA-ISBCS)
for
MCS vs ReLACS, Pain Perception Postoperative,
Location: Brampton
Sponsor: Uptown Eye Specialists
Sex: All
Age: 0+
Code: NCT05480839
Recruiting
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
for
B-Cell Non-Hodgkin Lymphoma, Multiple Myeloma
Location: Winston-Salem NC, Columbus OH, Irvine CA, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 60+
Code: NCT06052826
Phase2, Recruiting
Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies
for
Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT06227026
Phase1, Recruiting
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
for
Hematologic Malignancy, Bone Marrow Transplant Rejection,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: All
Age: 18+
Code: NCT06398457
Early_phase1, Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18 - 70+
Code: NCT05990465
Phase1, Recruiting
Living Well With Lymphoma
for
Lymphoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT06047626
Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma